Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk factors associated with extended-spectrum β-lactamase-producing organisms at a tertiary care hospital

25 May 2005

Abstract excerpt

BACKGROUND: In 1995, beta-lactam inhibitor combinations replaced third-generation cephalosporins as empirical therapy in an effort to manage extended-spectrum beta-lactamase (ESBL) resistance. This study investigated the relationship between antibiotic usage and ESBL organisms from 1994 through 2002 using epidemiological and molecular analysis. METHODS: A case-control study of 119 patients with ESBL organisms and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotic Use and Resistance
Share to Nosocomial Infections in ICU

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15917283
DOI: 10.1093/jac/dki180

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk factors associated with extended-spectrum β-lactamase-producing organisms at a tertiary care hospitalPMID 15917283Read ↗

Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.Semantic proximity Read ↗

Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients.Semantic proximity Read ↗

Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniaeSemantic proximity Read ↗

Clinical and Molecular Epidemiology of Extended-Spectrum β -Lactamase—Producing Escherichia coli as a Cause of Nosocomial Infection or Colonization: Implications for ControlSemantic proximity Read ↗

Risk Factors for Increasing Multidrug Resistance among Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella SpeciesSemantic proximity Read ↗

Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors.Semantic proximity Read ↗

Epidemiology and Risk Factors for Isolation of Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamase in a Large U.S. Medical CenterSemantic proximity Read ↗

Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum β-lactamase-producing Escherichia coli infections.Semantic proximity Read ↗

Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamasesSemantic proximity Read ↗

Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.Semantic proximity Read ↗

Risk factors for infections with extended- spectrum beta-lactamase-producing Escherichia coli in a county of Southern SwedenSemantic proximity Read ↗

OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producingEscherichia coliSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.